Yuval Horn, Assaf Unger and Ben Baharav represented INX Limited in the sale transaction of INX’s wholly owned subsidiary, I.L.S. Brokers Ltd., to a UK-based global financial services firm.
September 3, 2024
Horn & Co. contributed the Israeli chapter of the Thomson Reuters security considerations practice note.
June 11, 2024
Keren Kanir & Roy Ribon advised Savoreat Ltd. in a manufacturing agreement with a well known and veteran American manufacturer.
June 10, 2024
Shimrit Roznek moderated a panel about M&A in Life Sciences at the IBA WLSC Conference held in Madrid on May 29-30, 2024.
May 13, 2024
Yuval Horn co-chaired the IBA 10th World Life Sciences Conference to be held in Madrid on 29 -31 May, 2024.
May 12, 2024
Yuval Horn and Keren Kanir represented AIgnostics GMBH in a strategic collaboration agreement with Bayer.
March 14, 2024
Yuval Horn Co-chaired the International Bar Association 7th M&A in the Tech Sector Conference in Barcelona.
March 14, 2024
Yuval Horn, Shimrit Roznek and Yael Bar Hillel represented Metabomed Ltd. in its Asset Purchase Agreement with EpiVario Inc., for the sale of Metabomed’s small molecule acetyl co-A synthetase-2 inhibitor portfolio.
January 24, 2024
Yuval Horn, Yonatan Levinstein & Tal Gazanda represented Prisma Photonics in the Series C Investment agreement with IEC.
December 20, 2023
Despite the times, Yuval Horn Co-moderated a panel about #AI and Medical Devices at the #IBA Annual Conference in Paris.
November 2, 2023
